AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
All-In with Chamath, Jason, Sacks & Friedberg
E129: Sam Altman plays chess with regulators, AI's "nuclear" potential, big pharma bundling & more
May 19, 2023
01:28:05
AI Summary
Highlights
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- The FTC has filed a lawsuit to prevent Amgen's acquisition of Horizon Therapeutics, arguing that it could solidify a monopoly in the pharmaceutical market.
- Elon Musk has appointed Linda Yakareno as Twitter's CEO, allowing him to focus on technology and product development.
Deep dives
Amgen's Acquisition of Horizon Therapeutics Challenged by FTC
The FTC has filed a lawsuit seeking to prevent Amgen's acquisition of Horizon Therapeutics, valued at $27.8 billion. The FTC argues that the deal would allow Amgen to strengthen Horizon's monopoly positions in eye and gout drugs, potentially preventing competition and innovation in the market. The pharmaceutical industry operates differently from the tech industry, as the FDA's rigorous approval process ensures the safety and effectiveness of drugs. The acquisition is seen as an opportunity for Amgen to leverage Horizon's successful medications and expand their market presence.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode